ML
Michael J. LaBarre (SVP, CHIEF TECHNICAL OFFICER) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $1.1M of HALO (18,700 sh across 2 lots, as filed), executed Feb 25 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Feb 26 2025
Filed Feb 27 2025
Median ADV $214.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
HALORecent filings
HALOSALE
Halozyme Therapeutics, Inc.
View filing →
$1.1M18,700 sh across 2 lots
Exec Feb 25 2025
Filed Feb 27 2025 · 5:30 PM ET